KES has worked with Microbaric Oxygen Systems from their early days. We helped them develop their patents as well as provided expertise at different stages of their system’s development. We are excited their continued progress in assisting those with autism with their latest paper, “Evolution and Preliminary Testing of a Hyperoxic Therapy for Autism Spectrum Disorders,” (DOI: 10.4172/2165-7890.1000233). This complements their previous paper, “Hypothesis for How Hyperoxic Therapy May Facilitate Effective Biologic “Correction” of Autism Spectrum Disorders“. KES is proud to be able to contribute to this important work and look forward to its continued development.
Recent Posts
- KES at the 20th Annual Submarine Symposium
- KES presents three papers at ASME IMECE 2023 in New Orleans
- NICET selects Krista Kemper for key role in SSI certification program
- KES supporting Louisiana firm Enviro-Tech Systems on an international basis
- Presenting about AI and Foreign Relations to ISA South 2023
- Inaugural Forensic Fest at Liberty Magnet High School
- Bart Kemper installed as NSPE Fellow at NAFE conference in KC
- PRESS RELEASE: KES and OceanGate’s experimental submersible TITAN
Recent Comments